282 related articles for article (PubMed ID: 28863345)
1. The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells.
Vangapandu HV; Ayres ML; Bristow CA; Wierda WG; Keating MJ; Balakrishnan K; Stellrecht CM; Gandhi V
Neoplasia; 2017 Oct; 19(10):762-771. PubMed ID: 28863345
[TBL] [Abstract][Full Text] [Related]
2. B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia.
Vangapandu HV; Havranek O; Ayres ML; Kaipparettu BA; Balakrishnan K; Wierda WG; Keating MJ; Davis RE; Stellrecht CM; Gandhi V
Mol Cancer Res; 2017 Dec; 15(12):1692-1703. PubMed ID: 28835371
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Flux Assays to Determine Oxidative Phosphorylation and Glycolysis in Chronic Lymphocytic Leukemia Cells.
Vangapandu HV; Gandhi V
Methods Mol Biol; 2019; 1881():121-128. PubMed ID: 30350202
[TBL] [Abstract][Full Text] [Related]
4. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.
Balakrishnan K; Burger JA; Fu M; Doifode T; Wierda WG; Gandhi V
Neoplasia; 2014 Dec; 16(12):1036-46. PubMed ID: 25499217
[TBL] [Abstract][Full Text] [Related]
6. Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
Liu PP; Liu J; Jiang WQ; Carew JS; Ogasawara MA; Pelicano H; Croce CM; Estrov Z; Xu RH; Keating MJ; Huang P
Oncogene; 2016 Oct; 35(43):5663-5673. PubMed ID: 27065330
[TBL] [Abstract][Full Text] [Related]
7. Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells.
Vangapandu HV; Alston B; Morse J; Ayres ML; Wierda WG; Keating MJ; Marszalek JR; Gandhi V
Oncotarget; 2018 May; 9(38):24980-24991. PubMed ID: 29861847
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
[TBL] [Abstract][Full Text] [Related]
10. Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.
Prinz C; Vasyutina E; Lohmann G; Schrader A; Romanski S; Hirschhäuser C; Mayer P; Frias C; Herling CD; Hallek M; Schmalz HG; Prokop A; Mougiakakos D; Herling M
Mol Cancer; 2015 Jun; 14():114. PubMed ID: 26041471
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
12. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms.
Zhang W; Pelicano H; Yin R; Zeng J; Wen T; Ding L; Huang R
Mol Med Rep; 2015 Nov; 12(5):7374-88. PubMed ID: 26458979
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.
Gehrke I; Gandhirajan RK; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
Mol Med; 2011; 17(7-8):619-27. PubMed ID: 21519633
[TBL] [Abstract][Full Text] [Related]
14. Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis.
Böttcher M; Bruns H; Völkl S; Lu J; Chartomatsidou E; Papakonstantinou N; Mentz K; Büttner-Herold M; Zenz T; Herling M; Huber W; Ghia P; Stamatopoulos K; Mackensen A; Mougiakakos D
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931470
[TBL] [Abstract][Full Text] [Related]
15. Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.
Davids MS; Deng J; Wiestner A; Lannutti BJ; Wang L; Wu CJ; Wilson WH; Brown JR; Letai A
Blood; 2012 Oct; 120(17):3501-9. PubMed ID: 22955911
[TBL] [Abstract][Full Text] [Related]
16. TP53-induced glycolysis and apoptosis regulator protects from spontaneous apoptosis and predicts poor prognosis in chronic lymphocytic leukemia.
Hong M; Xia Y; Zhu Y; Zhao HH; Zhu H; Xie Y; Fan L; Wang L; Miao KR; Yu H; Miao YQ; Wu W; Zhu HY; Chen YY; Xu W; Qian SX; Li JY
Leuk Res; 2016 Nov; 50():72-77. PubMed ID: 27693855
[TBL] [Abstract][Full Text] [Related]
17. Metabolism pathways in chronic lymphocytic leukemia.
Rozovski U; Hazan-Halevy I; Barzilai M; Keating MJ; Estrov Z
Leuk Lymphoma; 2016; 57(4):758-65. PubMed ID: 26643954
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro.
Bäckman E; Bergh AC; Lagerdahl I; Rydberg B; Sundström C; Tobin G; Rosenquist R; Linderholm M; Rosén A
Haematologica; 2007 Nov; 92(11):1495-504. PubMed ID: 18024398
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia.
von Heydebrand F; Fuchs M; Kunz M; Voelkl S; Kremer AN; Oostendorp RAJ; Wilke J; Leitges M; Egle A; Mackensen A; Lutzny-Geier G
Stem Cells; 2021 Jun; 39(6):819-830. PubMed ID: 33539629
[TBL] [Abstract][Full Text] [Related]
20. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways?
Seke Etet PF; Vecchio L; Nwabo Kamdje AH
Cell Signal; 2012 Jul; 24(7):1433-43. PubMed ID: 22446006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
